MBA MD - Alpha Cognition Chief Officer

All Insiders . USA . 
Stock . Alpha Cognition . Stakeholders . Insider . MBA MD
ACOGF Stock  USD 6.62  0.05  0.75%   

Insider

MBA MD is Chief Officer of Alpha Cognition
Age 47
Webhttps://www.alphacognition.com

Alpha Cognition Management Efficiency

The company has return on total asset (ROA) of (1.6088) % which means that it has lost $1.6088 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9694) %, meaning that it generated substantial loss on money invested by shareholders. Alpha Cognition's management efficiency ratios could be used to measure how well Alpha Cognition manages its routine affairs as well as how well it operates its assets and liabilities.
Alpha Cognition has accumulated 1.14 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Alpha Cognition has a current ratio of 3.02, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Alpha Cognition until it has trouble settling it off, either with new capital or with free cash flow. So, Alpha Cognition's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alpha Cognition sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alpha to invest in growth at high rates of return. When we think about Alpha Cognition's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Stephen JDGeron
74
Sean FlynnVerastem
50
Jonathan PachterVerastem
66
Joseph FerraElevation Oncology
49
Daniel CalkinsVerastem
36
Erin CoxVerastem
N/A
Mba MBAVerastem
70
BPHARM RPhVerastem
63
Brian SullivanElevation Oncology
N/A
David DornanElevation Oncology
46
Christian MuellerImmutep Ltd ADR
N/A
Michelle MDVerastem
48
RPh PharmDElevation Oncology
40
Valerie MDElevation Oncology
46
Wolfgang MDRigel Pharmaceuticals
58
Robert WeinbergVerastem
N/A
Ryan BloomerElevation Oncology
N/A
Piyush GuptaVerastem
N/A
Shengfei FangImmutep Ltd ADR
N/A
Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimers disease and amyotrophic lateral sclerosis . Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada. Alpha Cognition is traded on OTC Exchange in the United States. Alpha Cognition [ACOGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-6.97
Return On Asset-1.61

Alpha Cognition Leadership Team

Elected by the shareholders, the Alpha Cognition's board of directors comprises two types of representatives: Alpha Cognition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alpha. The board's role is to monitor Alpha Cognition's management team and ensure that shareholders' interests are well served. Alpha Cognition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alpha Cognition's outside directors are responsible for providing unbiased perspectives on the board's policies.
LLB BA, Special Founder
Colleen Johns, VP Devel
Lauren MBA, Chief Officer
Denis Kay, Chief Officer
Donald BA, Chief Officer
Michael McFadden, CEO Director
MBA MD, Chief Officer

Alpha Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Alpha Cognition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-6.97
Return On Asset-1.61
Current Valuation14.92 M
Shares Outstanding61.02 M
Shares Owned By Insiders29.84 %
Shares Owned By Institutions0.73 %
Price To Book9.90 X
Gross Profit(37.5 K)
EBITDA(18.93 M)
Net Income(19.55 M)

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Alpha OTC Stock

Alpha Cognition financial ratios help investors to determine whether Alpha OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alpha with respect to the benefits of owning Alpha Cognition security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY